Clinical Trials Logo

Filter by:
NCT ID: NCT01371734 Completed - Clinical trials for Major Depressive Disorder

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Start date: August 2011
Phase: Phase 3
Study type: Interventional

This is a double-blind study evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) versus placebo in the Treatment of Children and Adolescent Outpatients with Major Depressive Disorder (MDD).

NCT ID: NCT01371721 Completed - Clinical trials for Major Depressive Disorder

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Start date: February 2012
Phase: Phase 3
Study type: Interventional

This is a 6-month, open-label, flexible-dose study evaluating desvenlafaxine succinate sustained release (DVS SR) in the treatment of child and adolescent outpatients with major depressive disorder (MDD).

NCT ID: NCT01370356 Completed - Smoking Cessation Clinical Trials

A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction

Start date: July 2011
Phase: Phase 4
Study type: Interventional

This study will determine whether varenicline is safe and helps people to quit smoking through reduction when they are not willing/able to make an abrupt quit attempt.

NCT ID: NCT01369563 Completed - Seasonal Rhinitis Clinical Trials

Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis

SISRIP
Start date: August 2011
Phase: N/A
Study type: Observational

To assess the efficacy, safety and tolerability of ciclesonide 200 mcg once daily, applied as a nasal spray for four weeks. The main outcome will be the improvement on global and individual typical and associated symptoms of intermittent or persistent rhinitis.

NCT ID: NCT01367665 Completed - Clinical trials for Basal Cell Carcinoma

STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Start date: July 1, 2011
Phase: Phase 2
Study type: Interventional

This single-arm, open-label, multi-center study will evaluate the safety and efficacy of vismodegib (GDC-0449) in patients with locally advanced or metastatic basal cell carcinoma. Patients will receive oral doses of vismodegib 150 mg once daily until disease progression or unacceptable toxicity.

NCT ID: NCT01365507 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens

BOOSTâ„¢
Start date: June 2011
Phase: Phase 3
Study type: Interventional

This trial is conducted in Asia and North America. The aim of this trial is to compare the efficacy and safety of insulin degludec/insulin aspart (IDegAsp) once daily in insulin-naïve subjects with type 2 diabetes mellitus when using two different titration algorithms (dose individually adjusted) as add-on to subject's ongoing treatment with metformin.

NCT ID: NCT01365455 Completed - Clinical trials for Moderate to Severe Plaque-type Psoriasis

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

ERASURE
Start date: June 2011
Phase: Phase 3
Study type: Interventional

This study will assess the safety and efficacy of secukinumab compared to placebo in patients that have moderate to severe, chronic, plaque-type psoriasis.

NCT ID: NCT01364597 Completed - Epilepsy Clinical Trials

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Start date: August 1, 2011
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and tolerability of brivaracetam in pediatric subjects with epilepsy.

NCT ID: NCT01364298 Completed - Clinical trials for Diabetic Peripheral Neuropathic Pain

Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management

Start date: April 2011
Phase: Phase 4
Study type: Interventional

This is a multicenter, randomized, open-label, parallel, Phase 4 clinical trial to compare efficacy and safety of gabapentin/B-complex versus pregabalin in diabetic peripheral neuropathy pain (DPNP) management.

NCT ID: NCT01363011 Completed - HIV Infections Clinical Trials

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Start date: May 2011
Phase: Phase 3
Study type: Interventional

This study is to characterize the effect of cobicistat-based regimens on parameters of renal function in subjects with HIV infection and who have mild to moderate renal impairment, and to assess the safety and tolerability of the regimens in order to generate appropriate dosing recommendations.